# COVID-19 Vaccine Boosters in Patients With CKD

Study · id `cardio:ct-nct05022329` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05022329](<https://clinicaltrials.gov/study/NCT05022329>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05022329

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 273 participants.

## Technical summary

Registry record NCT05022329. Randomized; triple masking; primary purpose prevention. Start 2021-09-30 (actual); primary completion 2022-05-11 (actual). Results posted on 2025-02-19.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 273 participants (enrolled count; ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Started: 2021-09-30 (actual) (ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Primary completion: 2022-05-11 (actual) (ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Completion: 2022-11-15 (actual) (ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Results first posted: 2025-02-19 (ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT05022329, source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05022329-2025-02-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: COVID-19 Vaccine Boosters in Patients With CKD
- Acronym: BOOST KIDNEY
- Condition: Chronic Kidney Diseases
- Condition: COVID-19
- Intervention (Biological): Pfizer-BioNTech COVID-19 Vaccine
- Intervention (Biological): MODERNA SARS-CoV-2 Vaccine
- Lead sponsor: Sunnybrook Health Sciences Centre
- Lead sponsor class: OTHER
- Collaborator: University Health Network, Toronto
- Collaborator class: OTHER
- Collaborator: Unity Health Toronto
- Collaborator class: OTHER
- Collaborator: Scarborough General Hospital
- Collaborator class: OTHER
- Collaborator: Providence Healthcare
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)
- Registry lists this organization as a collaborator: University Health Network, Toronto (`cardio:org-university-health-network-toronto`)
- Registry lists this organization as a collaborator: Unity Health Toronto (`cardio:org-unity-health-toronto`)
- Registry lists this organization as a collaborator: Scarborough General Hospital (`cardio:org-scarborough-general-hospital`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients (`cardio:pubmed-37847518`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 47629be5f1770f1530b5b05f2ee08026d5ad2794bb7f035210ffe95a26550ec0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
